ArticleFrontiers in genetics2025
Geographical distribution of ALDH2 rs671 polymorphism in Chinese angina pectoris patients.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mitochondrial acetaldehyde dehydrogenase 2 (ALDH2) plays a critical role in the metabolism of ethanol and nitroglycerin. Mutations in ALDH2 reduce enzymatic activity, impairing nitroglycerin metabolism. ALDH2 genetic polymorphisms exhibit significant regional variations across China. This study investigates the distribution of ALDH2 allelic and genotypic frequencies in patients with angina pectoris across northern (Luoyang, Henan), eastern (Jiaxing, Zhejiang), and southern (Guilin, Guangxi) China, and explores the relationship between ALDH2 genotypes and selected clinical characteristics. Materials and Methods: A total of 1,084 angina pectoris patients were recruited from the three aforementioned regions. ALDH2 genotyping was performed using fluorescence quantitative PCR, and associations between genotypes and clinical characteristics, such as smoking and alcohol consumption histories, were analyzed. Results: The geographical distribution of the ALDH2 rs671 G→A mutation showed a significant increase in mutation frequency from northern to southern China. Genotypic distributions differed significantly across regions, with GG being predominant in northern China and higher frequencies of GA and AA observed in southern regions. Additionally, lifestyle factors such as smoking and alcohol consumption were significantly associated with the presence of the A allele, reflecting the interplay between genetics and environmental influences. Conclusion: This study reveals significant regional differences in ALDH2 rs671 polymorphism and its association with lifestyle factors in angina pectoris patients across China. Since the ALDH2*2 variant markedly reduces the metabolic activation of nitroglycerin, these findings have important clinical implications: in regions with a higher prevalence of the A allele, patients may exhibit reduced therapeutic response to nitroglycerin. This highlights the need for region-specific and genotype-informed strategies in the management of angina pectoris.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.